Singapore markets open in 5 hours 58 minutes

TG Therapeutics, Inc. (NKB2.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
16.47+0.55 (+3.46%)
As of 08:05AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
41,197
12,672
-198,335
-348,101
-279,381
Depreciation & amortisation
384
423
515
494
374
Stock-based compensation
40,449
37,933
19,185
61,274
80,289
Change in working capital
-62,402
-84,659
-1,647
-12,216
-19,757
Accounts receivable
-56,359
-51,093
1,389
-1,389
0
Inventory
-46,945
-36,938
0
0
-
Accounts payable
-
-
-
-
11,631
Other working capital
20,282
-31,413
-176,184
-296,035
-214,864
Other non-cash items
4,454
4,454
4,443
2,398
3,998
Net cash provided by operating activities
20,282
-31,413
-176,170
-295,634
-214,507
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-14
-401
-357
Purchases of investments
-207,368
-146,880
-107,274
-55,531
-67,403
Sales/maturities of investments
153,630
96,229
87,275
55,600
43,250
Net cash used for investing activities
-53,738
-50,651
-20,013
-332
-24,510
Cash flows from financing activities
Debt repayment
-
0
-975
-30,000
0
Common stock issued
-
46,296
0
2,219
679,680
Dividends paid
-
-
-
0
0
Other financing activities
-
-125
-
-1,016
-
Net cash used provided by (used for) financing activities
47,477
72,705
-391
41,419
679,827
Net change in cash
14,021
-9,359
-196,574
-254,547
440,810
Cash at beginning of period
62,745
103,577
300,151
554,698
113,888
Cash at end of period
76,766
94,218
103,577
300,151
554,698
Free cash flow
Operating cash flow
20,282
-31,413
-176,170
-295,634
-214,507
Capital expenditure
-
-
-14
-401
-357
Free cash flow
20,282
-31,413
-176,184
-296,035
-214,864